3 results
This is a phase III, open-label, multicenter, randomized study to investigate the efficacy and safety of atezolizumab (anti PDL1 antibody) compared with chemotherapy in patients with locally advanced or metastatic urothelial bladder cancer after…
The primary objective of this study is to compare the overall survival (OS) distributions between LY2157299 monohydrate plus lomustine therapy with lomustine plus placebo therapy (control arm), in patients who have relapsed or have progressive GB…
Primary objective:* Assess the test-retest repeatability and reproducibility of radioligand [11C]-UCB-J binding.Secondary objective:* Compare the precision and accuracy of PET data analysis using 60 versus 90 minutes of scan data.* Assess group…